Novanta Inc. (NOVT): Price and Financial Metrics
NOVT Price/Volume Stats
Current price | $168.93 | 52-week high | $187.60 |
Prev. close | $173.25 | 52-week low | $111.20 |
Day low | $168.52 | Volume | 104,500 |
Day high | $175.40 | Avg. volume | 133,043 |
50-day MA | $162.81 | Dividend yield | N/A |
200-day MA | $158.34 | Market Cap | 6.06B |
NOVT Stock Price Chart Interactive Chart >
NOVT POWR Grades
- NOVT scores best on the Momentum dimension, with a Momentum rank ahead of 78.23% of US stocks.
- The strongest trend for NOVT is in Stability, which has been heading down over the past 26 weeks.
- NOVT ranks lowest in Value; there it ranks in the 3rd percentile.
NOVT Stock Summary
- NOVT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 582.97 -- higher than 94.62% of US-listed equities with positive expected earnings growth.
- NOVT's current price/earnings ratio is 73.78, which is higher than 91.43% of US stocks with positive earnings.
- The price/operating cash flow metric for NOVANTA INC is higher than 92.49% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to NOVANTA INC, a group of peers worth examining would be DV, NBIX, VMEO, ZBRA, and ENTG.
- NOVT's SEC filings can be seen here. And to visit NOVANTA INC's official web site, go to www.novanta.com.
NOVT Valuation Summary
- NOVT's price/earnings ratio is 72.9; this is 173.55% higher than that of the median Technology stock.
- Over the past 243 months, NOVT's price/sales ratio has gone up 3.7.
Below are key valuation metrics over time for NOVT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
NOVT | 2023-12-08 | 6.2 | 8.5 | 72.9 | 51.8 |
NOVT | 2023-12-07 | 6.1 | 8.4 | 71.7 | 51.1 |
NOVT | 2023-12-06 | 6.1 | 8.4 | 71.4 | 50.8 |
NOVT | 2023-12-05 | 5.9 | 8.1 | 69.5 | 49.6 |
NOVT | 2023-12-04 | 6.0 | 8.3 | 70.6 | 50.4 |
NOVT | 2023-12-01 | 6.0 | 8.2 | 70.0 | 49.9 |
NOVT Growth Metrics
- Its 4 year revenue growth rate is now at 54.77%.
- The 2 year cash and equivalents growth rate now stands at 34.06%.
- The 4 year cash and equivalents growth rate now stands at -7.89%.
The table below shows NOVT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 841.49 | 78.88 | 72.543 |
2022-06-30 | 796.258 | 78.019 | 63.656 |
2022-03-31 | 748.425 | 82.704 | 57.841 |
2021-12-31 | 706.793 | 94.625 | 50.331 |
2021-09-30 | 655.331 | 112.465 | 49.233 |
2021-06-30 | 620.534 | 140.681 | 43.888 |
NOVT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- NOVT has a Quality Grade of B, ranking ahead of 88.22% of graded US stocks.
- NOVT's asset turnover comes in at 0.719 -- ranking 22nd of 53 Electrical Equipment stocks.
- AME, BYRN, and CCF are the stocks whose asset turnover ratios are most correlated with NOVT.
The table below shows NOVT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-02 | 0.719 | 0.423 | 0.128 |
2021-04-02 | 0.696 | 0.416 | 0.120 |
2020-12-31 | 0.690 | 0.414 | 0.124 |
2020-10-02 | 0.703 | 0.412 | 0.111 |
2020-07-03 | 0.716 | 0.412 | 0.109 |
2020-04-03 | 0.745 | 0.417 | 0.111 |
NOVT Price Target
For more insight on analysts targets of NOVT, see our NOVT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $145.00 | Average Broker Recommendation | 1.88 (Hold) |
Novanta Inc. (NOVT) Company Bio
Novanta Inc. designs, develops, manufactures, and sells precision photonic and motion control components, and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. The company operates through three segments: Laser Products, Vision Technologies, and Precision Motion. The company was founded in 1968 and is based in Bedford, Massachusetts.
Latest NOVT News From Around the Web
Below are the latest news stories about NOVANTA INC that investors may wish to consider to help them evaluate NOVT as an investment opportunity.
Is the Growth Rate of Novanta (NOVT) Going to Pick Up Again?Wasatch Global Investors, an investment management firm, released its “Wasatch U.S. Select Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Concerns about the impact of rising interest rates and the possibility of a recession caused stocks to decline in the third quarter. In this context, the fund’s Investor […] |
Novanta Inc CFO Robert Buckley Sells 6,000 SharesOn December 19, 2023, Robert Buckley, the CFO of Novanta Inc (NASDAQ:NOVT), sold 6,000 shares of the company's stock, according to a recent SEC Filing. |
14 Best Automation Stocks To Buy NowIn this article, we discuss the 14 best automation stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Automation Stocks To Buy Now. Automation is a trend that has been sweeping across the business world for the past few decades, making headlines every now […] |
Novanta to Present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024BEDFORD, Mass., December 13, 2023--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, Chuck Ravetto, Group President, and Ray Nash, Vice President, Corporate Finance, are scheduled to present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024, which is being held virtually. |
Novanta to Present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024BEDFORD, Mass., December 11, 2023--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024, in San Francisco, California. |
NOVT Price Returns
1-mo | 4.91% |
3-mo | 2.75% |
6-mo | 18.93% |
1-year | 12.04% |
3-year | 27.75% |
5-year | 99.30% |
YTD | 0.31% |
2023 | 23.95% |
2022 | -22.95% |
2021 | 49.15% |
2020 | 33.67% |
2019 | 40.38% |
Continue Researching NOVT
Want to see what other sources are saying about Novanta Inc's financials and stock price? Try the links below:Novanta Inc (NOVT) Stock Price | Nasdaq
Novanta Inc (NOVT) Stock Quote, History and News - Yahoo Finance
Novanta Inc (NOVT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...